Subscribe to Pro or Enterprise plans to unlock this feature.
Become a smarter investor today.
Become a smarter investor today.
This chart shows Merck’s Revenue by Region, across Asia Pacific, China, Europe, Middle East, Africa, Japan, Latin America and United States, reported annually from 2019 onwards.
|Region||2019||2020||2021||Contribution in 2021|
|Asia Pacific (other than Japan and China)||$2.94||$2.86||$2.40||4.92%|
|Europe, Middle East, and Africa||$12.71||$13.60||$13.34||27.39%|
(All the figures in billions, except percentages)
Merck reported a total revenue of $46.84 billion in 2019, which further increased to $47.99 billion in 2020, indicating a growth of 2.45%. Further, in the year 2021, it earned revenue of $48.70 billion, marking a growth of 0.85%.
United States is the highest contributor of revenue among all regions of the company. It contributes around 47% to the total revenue of the company by region, every year. Europe, the Middle East, and Africa is the second-highest revenue contributor among all regions. It contributes around 28% to the total revenue of the company region. Other is the least revenue contributor among all regions and contributes around 3% to the revenue of the company by region.
Merck’s Revenue by Region is further bifurcated into:
Asia Pacific (other than Japan and China)
In the year 2019, the Asia Pacific (other than Japan and China) region earned $2.94 billion, which showed a decline of 2.72%, by earning revenue of $2.86 in 2020. In 2021, this region reported revenue of $2.40 billion, down by 16.08%. It contributed 4.92% to the total revenue in 2021.
China region reported a revenue of $3.21 billion in 2019, which further increased to $3.62 billion in 2020, indicating a growth of 12.77%. In 2021, this region earned a revenue of $4.38 billion, which was up by 21%. It contributed 8.99% to the total revenue in 2021.
In 2019, the Europe, Middle East, and Africa region earned $12.71 billion, which further increased to $13.60 billion in 2020, indicating a growth of 7.01%. In 2021, revenue was $13.34 billion, which showed a decline of 1.95% as compared to 2020. In 2021, this region contributed 27.39% to the total revenue in 2021.
The Japan region earned $3.58 billion in 2019, however further it showed a decline of 5.59%, falling to $3.38 billion in 2020. Further, it decreased to $2.72 billion in 2021, falling by 19.52%. This region contributed 5.58% to the total revenue in 2021.
The Latin American region reported revenue of $2.74 in 2019. Further, it showed a decline by earning revenue of $2.27 billion in 2020, falling by 17.15%. Similarly, in 2021, the revenue decreased to $2.21 billion, declining by 2.64%. Latin America contributed 4.53% to the total revenue in 2021.
The United States earned revenue of $20.33 billion in the year 2019, further it increased to $21.02 in the year 2020, indicating a year-on-year growth of 3.39%. In the year 2021, the revenue from this region increased to $22.42 billion, indicating a year-on-year growth of 6.66%. The United States region, being the domicile country of the company, contributed 46.04% to the total revenue by region.
The others region includes countries other than those mentioned above. This region reported a revenue of $1.61 billion in 2019. However, further it showed a decline of 23.60%, as compared to 2020, where the revenue was $1.23 billion. It showed a continuous decline and stood at $1.22 billion in 2021, showing a fall of 0.81%. This region contributed 2.50% to the total revenue in 2021.
Merck & Co., headquartered in Kenilworth, New Jersey, United States, is an American public company operating globally. The enterprise deals in pharmaceutical, and create generic drugs, and medicines. It was founded on 1 January 1891, by George Merck.
Did you like Merck’s Revenue by Region statistic?
Access more such KPI data points and segment financials on thousands of US stocks, with Business Quant.
You can get started here.
Always know what you’ll pay. No hidden costs or surprises.
* Billed annually, local taxes extra.
* Local taxes extra.